These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 2995571)

  • 21. Identification of monoclonal antibodies that distinguish between 17D-204 and other strains of yellow fever virus.
    Barrett AD; Mathews JH; Miller BR; Medlen AR; Ledger TN; Roehrig JT
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():13-8. PubMed ID: 1689367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Monoclonal antibodies to flavivirus antigens induced by a vaccinal strain of yellow fever].
    Gaĭdamovich SIa; Mel'nikova EE; Mikheeva TG; Shutkova TM; Sveshnikova NA
    Vopr Virusol; 1988; 33(4):461-5. PubMed ID: 2848367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes.
    Guirakhoo F; Kitchener S; Morrison D; Forrat R; McCarthy K; Nichols R; Yoksan S; Duan X; Ermak TH; Kanesa-Thasan N; Bedford P; Lang J; Quentin-Millet MJ; Monath TP
    Hum Vaccin; 2006; 2(2):60-7. PubMed ID: 17012873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigenic analysis of flaviviruses with monoclonal antibodies against Negishi virus.
    Furuta I; Takashima I; Arikawa J; Hashimoto N
    Microbiol Immunol; 1984; 28(9):1023-30. PubMed ID: 6096680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
    J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies.
    Mishra N; Boudewijns R; Schmid MA; Marques RE; Sharma S; Neyts J; Dallmeier K
    mBio; 2020 Apr; 11(2):. PubMed ID: 32265332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different Cross-Reactivities of IgM Responses in Dengue, Zika and Tick-Borne Encephalitis Virus Infections.
    Stiasny K; Malafa S; Aberle SW; Medits I; Tsouchnikas G; Aberle JH; Holzmann H; Heinz FX
    Viruses; 2021 Mar; 13(4):. PubMed ID: 33807442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary antibody responses of herons to experimental infection with Murray Valley encephalitis and Kunjin viruses.
    Boyle DB; Marshall ID; Dickerman RW
    Aust J Exp Biol Med Sci; 1983 Dec; 61 ( Pt 6)():665-74. PubMed ID: 6326725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limitations of the complement-fixation test for distinguishing naturally acquired from vaccine-induced yellow fever infection in flavivirus-hyperendemic areas.
    Monath TP; Craven RB; Muth DJ; Trautt CJ; Calisher CH; Fitzgerald SA
    Am J Trop Med Hyg; 1980 Jul; 29(4):624-34. PubMed ID: 7406113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advancement in flavivirus vaccine development.
    Chang GJ; Kuno G; Purdy DE; Davis BS
    Expert Rev Vaccines; 2004 Apr; 3(2):199-220. PubMed ID: 15056045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mapping the diverse structural landscape of the flavivirus antibody repertoire.
    Sevvana M; Kuhn RJ
    Curr Opin Virol; 2020 Dec; 45():51-64. PubMed ID: 32801077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specificities of human CD4+ T cell responses to an inactivated flavivirus vaccine and infection: correlation with structure and epitope prediction.
    Schwaiger J; Aberle JH; Stiasny K; Knapp B; Schreiner W; Fae I; Fischer G; Scheinost O; Chmelik V; Heinz FX
    J Virol; 2014 Jul; 88(14):7828-42. PubMed ID: 24789782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of antibodies to tickborne encephalitis and West Nile flaviviruses and the clinical signs of tickborne encephalitis in dogs in the Czech Republic.
    Klimes J; Juricová Z; Literák I; Schánilec P; Trachta e Silva E
    Vet Rec; 2001 Jan; 148(1):17-20. PubMed ID: 11200400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Highly specific detection of antibodies to tick-borne encephalitis (TBE) virus in humans using a domain III antigen and a sensitive immune complex (IC) ELISA.
    Ludolfs D; Reinholz M; Schmitz H
    J Clin Virol; 2009 Jun; 45(2):125-8. PubMed ID: 19409841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1987 yellow fever epidemics in Oyo State, Nigeria: a survey for yellow fever virus haemagglutination inhibiting antibody in residents of two communities before and after the epidemics.
    Olaleye OD; Omilabu SA; Faseru O; Fagbami AH
    Virologie; 1988; 39(4):261-6. PubMed ID: 2851207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutralization of yellow fever virus studied using monoclonal and polyclonal antibodies.
    Buckley A; Gould EA
    J Gen Virol; 1985 Dec; 66 ( Pt 12)():2523-31. PubMed ID: 2999305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunochip for differentiation of IgG to tick-borne encephalitis and West Nile fever viruses].
    Pomelova VG; Bychenkova TA; Bekman NI; Osin NS
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (1):62-7. PubMed ID: 20218348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Priming with Japanese encephalitis virus or yellow fever virus vaccination led to the recognition of multiple flaviviruses without boosting antibody responses induced by an inactivated Zika virus vaccine.
    Li Y; Merbah M; Wollen-Roberts S; Beckman B; Mdluli T; Curtis DJ; Currier JR; Mendez-Rivera L; Dussupt V; Krebs SJ; De La Barrera R; Michael NL; Paquin-Proulx D; Eller MA; Koren MA; Modjarrad K; Rolland M
    EBioMedicine; 2023 Nov; 97():104815. PubMed ID: 37793212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of neutralizing antibodies to West Nile virus.
    Sánchez MD; Pierson TC; McAllister D; Hanna SL; Puffer BA; Valentine LE; Murtadha MM; Hoxie JA; Doms RW
    Virology; 2005 May; 336(1):70-82. PubMed ID: 15866072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Failure of Japanese encephalitis vaccine and infection in inducing neutralizing antibodies against West Nile virus, People's Republic of China.
    Tang F; Zhang JS; Liu W; Zhao QM; Zhang F; Wu XM; Yang H; Ly H; Cao WC
    Am J Trop Med Hyg; 2008 Jun; 78(6):999-1001. PubMed ID: 18541783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.